x
Filter:
Filters applied
- Editorials
- Reddy, Yogesh NVRemove Reddy, Yogesh NV filter
Publication Date
Please choose a date range between 2019 and 2022.
Editorials
4 Results
- Editorial
Portopulmonary Hypertension—Rethinking Our Current Approach
Mayo Clinic ProceedingsVol. 97Issue 12p2189–2191Published in issue: December, 2022- Yogesh N.V. Reddy
Cited in Scopus: 0Patients with cirrhosis have progressive liver disease with secondary neurohormonal activation resulting in volume overload. This neurohormonal activation is due to “arterial underfilling” from a pathologically decreased systemic vascular resistance (SVR), and this is associated with a reflex increase in cardiac output (CO) to maintain blood pressure.1 When this decrease in blood pressure is sensed by arterial baroreceptors, there is secondary renin-angiotensin-aldosterone activation, which results in renal sodium retention and volume overload despite normal heart function. - Editorial
Heart Failure With Preserved Ejection Fraction: Where Do We Stand?
Mayo Clinic ProceedingsVol. 95Issue 4p629–631Published in issue: April, 2020- Yogesh N.V. Reddy
- Barry A. Borlaug
Cited in Scopus: 1Dyspnea is one of the commonest complaints encountered in practice. Etiologies span the gamut of internal medicine and range from anemia to deconditioning to pulmonary and cardiac disorders. In the latter category, heart failure (HF) is one of the more common and serious causes of dyspnea and also one of the most challenging to diagnose.1 In patients with classical symptoms (orthopnea, paroxysmal nocturnal dyspnea) and unequivocal congestion on physical examination (jugular distention, edema, rales, gallop sounds), the diagnosis is straightforward. - Editorial
The Changing Landscape of Treatment for Aortic Stenosis: Continuing to Push the Boundaries
Mayo Clinic ProceedingsVol. 95Issue 1p9–11Published in issue: January, 2020- Yogesh N.V. Reddy
- Rick A. Nishimura
Cited in Scopus: 0There has been an ongoing evolution in our understanding and subsequent management of the patient with aortic stenosis (AS). Valvular AS presents a mechanical obstruction to ventricular ejection at the aortic valve level, worsens over time, and with the onset of symptoms there is a rapidly declining course resulting in progressive heart failure and death. The advent of surgical aortic valve replacement (SAVR) nearly 60 years ago has been lifesaving for many patients with symptomatic severe AS, restoring quality of life to those with severe limiting symptoms. - Editorial
Readmissions in Heart Failure: It’s More Than Just the Medicine
Mayo Clinic ProceedingsVol. 94Issue 10p1919–1921Published in issue: October, 2019- Yogesh N.V. Reddy
- Barry A. Borlaug
Cited in Scopus: 10Heart failure (HF) is one of the commonest causes of hospitalization and accounts for more than $30 billion of the US health care expenditure annually. In addition to these economic implications, hospitalization for HF represents a watershed event signifying high risk for readmission and poor outcomes. Accordingly, there has been tremendous interest in reducing HF readmissions, with efforts on the medical front including in-hospital drug initiation, remote monitoring, and early follow-up1; additional effort also occurs at the national policy level through implementation of financial penalties for hospitals in the event of HF readmissions within 30 days of discharge.
